Recurrent Rectal Cancer
82
2
3
54
Key Insights
Highlights
Success Rate
76% trial completion
Published Results
24 trials with published results (29%)
Research Maturity
54 completed trials (66% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 74/100
20.7%
17 terminated out of 82 trials
76.1%
-10.5% vs benchmark
7%
6 trials in Phase 3/4
44%
24 of 54 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 54 completed trials
Clinical Trials (82)
Sorafenib and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
Hypofractionated Pencil-Beam Scanning Intensity-modulated Proton Therapy (IMPT) in Recurrent Rectal Cancer
Panitumumab and Chemotherapy in Patients With Advanced Colorectal Cancer After Prior Therapy With Bevacizumab
Preoperative Chemoradiotherapy and Toripalimab in Locally Recurrent Rectal Cancer
The Combination of Hypofractionated Radiotherapy and Immunotherapy in Locally Recurrent Rectal Cancer
Genetic Mutations in Blood and Tissue Samples in Predicting Response to Treatment in Patients With Locally Advanced Rectal Cancer Undergoing Chemoradiation
VEGF Trap in Treating Patients With Previously Treated Metastatic Colorectal Cancer
Vaccine Therapy in Treating Patients With Colon, Pancreatic, or Lung Cancer
Ipilimumab and Local Radiation for Selected Solid Tumors
Magnetic Resonance-Guided High Intensity Focused Ultrasound for Recurrent Rectal Cancer
Isolated Hepatic Perfusion With Melphalan Followed By Chemotherapy in Treating Patients With Unresectable Colorectal Cancer That is Metastatic to the Liver
Trametinib, Fluorouracil, and Radiation Therapy Before Surgery in Treating Patients With Stage II-III Rectal Cancer
CPI-613 and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surgery
Induction Chemotherapy for Locally Recurrent Rectal Cancer
Chemoembolization Using Irinotecan in Treating Patients With Liver Metastases From Metastatic Colon or Rectal Cancer
Body Composition Manipulation in CoLorectal cancEr (BiCyCLE): Neuromuscular Electrical Stimulation (NMES)
Comprehensive Gene Sequencing in Guiding Treatment Recommendations Patients With Metastatic or Recurrent Solid Tumors
PelvEx 4: Advanced Pelvic Malignancy and the Role of the Multi-disciplinary Team Meeting
Phase I Study of Neoadjuvant Radiotherapy With 5-Fluorouracil for Rectal Cancer
PET-MRI in Diagnosing Patients With Colon or Rectal Cancer